Rocket Lab USA, Inc. Securities Class Action Litigation

Introduction

Securities class action litigation has been filed on behalf of investors who purchased or acquired the securities of Rocket Lab USA, Inc. (“Rocket Lab” or the “Company”) between November 12, 2024 and February 25, 2025, inclusive (the “Class Period”).

If you purchased Rocket Lab securities during the Class Period, you may move the Court for appointment as lead plaintiff by no later than April 28, 2025.

A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Your share of any recovery in the actions will not be affected by your decision of whether to seek appointment as lead plaintiff. You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.

Rocket Lab investors who wish to learn more about the litigation and how to seek appointment as lead plaintiff should complete the form below, text or email investorinfo@lchb.com, or call Lieff Cabraser partner Sharon M. Lee at 1-800-541-7358.

Background on the Rocket Lab Securities Class Action Litigation

Rocket Lab, headquartered in Long Beach, California, provides launch and spacecraft design services, spacecraft components and manufacturing, and other spacecraft and on-orbit management solutions. In March 2021, Rocket Lab announced development plans for the Neutron Launch Vehicle (“Neutron”), a reusable, medium-capacity rocket to increase the payload capacity of its space launch vehicle. In 2024, the Company announced a schedule to conduct one Neutron test launch of in mid-2025, three commercial launches in 2026, and five in 2027.

The action alleges that, throughout the Class Period, Rocket Lab and certain of its senior executives failed to disclose to investors that: (1) the Company’s plans for three barge landing tests were significantly delayed; (2) a critical potable water issue was not scheduled to be fixed until January 2026, delaying the preparation of Neutron’s launch pad; (3) as a result, there was a substantial risk that Neutron would not launch in the middle of 2025; (4) Rocket Lab’s only contract secured for Neutron was significantly discounted, with an unreliable partner; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On February 25, 2025, Bleecker Street Research released a report claiming that Rocket Lab had misled investors about the likelihood that the Neutron rocket would launch in the middle of 2025. The report revealed that the Company was delaying three barge landing tests until between September 2025 and March 2026, instead of between September 2024 and March 2025 as originally planned. The report also uncovered a significant delay in preparing the Neutron’s launching pad, including a potable water problem that was not scheduled to be fixed until January 2026. Additionally, the report alleged that the only Neutron contract the Company had secured was with an “unreliable startup,” which was not even “a full-price deal, contrary to what Rocket Lab has said.” On this news, Rocket Lab’s stock price fell $2.21 per share, or 9.83%, from its closing price of $22.49 per share on February 24, 2025, to close at $20.28 per share on February 25, 2025.